Insights into MAPK p38alpha DFG flip mechanism by accelerated molecular dynamics.

[1]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.

[2]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[3]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[4]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[5]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997 .

[6]  G. Bemis,et al.  The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. , 1997, Chemistry & biology.

[7]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[8]  John C. Lee,et al.  p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. , 2001, Progress in medicinal chemistry.

[9]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[10]  V. Barone,et al.  MD simulation of the Na+-phenylalanine complex in water: competition between cation-pi interaction and aqueous solvation. , 2005, The journal of physical chemistry. B.

[11]  Jon Read,et al.  Prevention of MKK6-dependent activation by binding to p38alpha MAP kinase. , 2005, Biochemistry.

[12]  Christopher W Murray,et al.  Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation. , 2005, Journal of medicinal chemistry.

[13]  Adrian H Elcock,et al.  Computational sampling of a cryptic drug binding site in a protein receptor: explicit solvent molecular dynamics and inhibitor docking to p38 MAP kinase. , 2006, Journal of molecular biology.

[14]  Harald Schwalbe,et al.  NMR characterization of kinase p38 dynamics in free and ligand-bound forms. , 2006, Angewandte Chemie.

[15]  Susan S. Taylor,et al.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.

[16]  N. Gray,et al.  Rational design of inhibitors that bind to inactive kinase conformations , 2006, Nature chemical biology.

[17]  Taebo Sim,et al.  A general strategy for creating "inactive-conformation" abl inhibitors. , 2006, Chemistry & biology.

[18]  E. Springman,et al.  Mutagenesis of p38alpha MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-OUT state. , 2010, Biochemistry.

[19]  Paul Bamborough,et al.  Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes. , 2008, Bioorganic & medicinal chemistry letters.

[20]  R. Abagyan,et al.  Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states. , 2008, Journal of medicinal chemistry.

[21]  Jyothi Subramanian,et al.  Modeling and Selection of Flexible Proteins for Structure‐Based Drug Design: Backbone and Side Chain Movements in p38 MAPK , 2008, ChemMedChem.

[22]  R. Dror,et al.  A conserved protonation-dependent switch controls drug binding in the Abl kinase , 2009, Proceedings of the National Academy of Sciences.

[23]  Hendrik Zipse,et al.  Explicit solvent effect on cation-pi interactions: a first principle investigation. , 2009, The journal of physical chemistry. B.

[24]  Daniel Rauh,et al.  Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors. , 2009, Journal of the American Chemical Society.

[25]  Daniel Rauh,et al.  High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha. , 2009, Journal of the American Chemical Society.

[26]  T. Clackson,et al.  Structural Analysis of DFG‐in and DFG‐out Dual Src‐Abl Inhibitors Sharing a Common Vinyl Purine Template , 2009, Chemical biology & drug design.

[27]  C. Grütter,et al.  Fluorophore labeling of the glycine-rich loop as a method of identifying inhibitors that bind to active and inactive kinase conformations. , 2010, Journal of the American Chemical Society.

[28]  E. Casale,et al.  Through the "gatekeeper door": exploiting the active kinase conformation. , 2010, Journal of medicinal chemistry.